This effect is particularly notable in patients with obesity and those without diabetes [54]
Once approved, the processor pays the claim, and the pharmacy coordinates the release of your medication
GLP-1, short for Glucagon-like peptide-1, is a hormone that enhances insulin secretion and suppresses glucagon release, slowing down digestion
However, these medications may come with some side effects , including nausea, vomiting, diarrhea, and abdominal discomfort, particularly when starting the treatment
NHS services regularly provide refresher sessions, especially for people who self-inject long-term or have changes in body weight